Opioid withdrawal follows a predictable timeline that depends on which opioid was used. Short-acting opioids like heroin and oxycodone produce withdrawal symptoms within 8 to 12 hours of the last dose, peaking at 36 to 72 hours, and largely resolving within 5 to 7 days. Long-acting opioids like methadone produce withdrawal beginning at 24 to 48 hours, peaking around day 4 to 6, and lasting up to 14 to 21 days. Fentanyl withdrawal can begin as early as 4 to 6 hours after the last dose. While opioid withdrawal is intensely uncomfortable, it is rarely life-threatening with appropriate medical support.
What Drives the Withdrawal Timeline
“The timeline of opioid withdrawal is dictated by pharmacology, not willpower,” says Dr. Ponlawat Pitsuwan, Physician at Phuket Island Rehab. “When a patient understands that their symptoms follow a predictable sequence, and that the worst will pass within a defined window, it changes their relationship with the process. The suffering is still real, but it is no longer infinite and unknowable.”
Opioid withdrawal occurs because the brain has adapted to the chronic presence of opioids by downregulating its own endorphin production and upregulating excitatory neurotransmitter systems (particularly norepinephrine in the locus coeruleus). When the opioid is removed, these compensatory changes are exposed: the brain is simultaneously under-producing its own pain-relieving chemicals and over-producing the chemicals that create agitation, anxiety, and sympathetic nervous system activation. The result is the characteristic withdrawal syndrome.
The speed at which withdrawal begins depends on the opioid’s half-life. Heroin has a half-life of approximately 30 minutes, meaning it is rapidly cleared and withdrawal begins quickly. Oxycodone has a half-life of 3 to 5 hours. Fentanyl has a half-life of 3 to 7 hours but can accumulate in fat tissue, creating a more complex withdrawal pattern. Methadone has a half-life of 24 to 36 hours, explaining its much later onset and longer duration of withdrawal.
The Timeline: Phase by Phase
Hours 6 to 24: Early Withdrawal
The first symptoms resemble a severe flu. Anxiety appears first, often described as a creeping sense of dread that builds over several hours. Muscle aches follow, initially mild but intensifying. The person begins yawning excessively, a specific sign of early opioid withdrawal that is often the first objective symptom noticed by clinicians. Eyes begin watering (lacrimation), the nose begins running (rhinorrhea), and sweating starts.
Sleep becomes impossible or fragmented. The autonomic nervous system begins its revolt: heart rate increases, blood pressure rises slightly, and a general sense of restlessness makes sitting still feel unbearable. Cravings intensify as the brain recognises the absence of the opioid and generates powerful urge signals. This early phase is when the risk of resuming use is highest because the person knows that a single dose will make everything stop.
Hours 24 to 72: Peak Withdrawal
This is the most intense phase. The gastrointestinal symptoms that define opioid withdrawal in the public imagination emerge in force: nausea, vomiting, diarrhoea, and abdominal cramping. These symptoms result from the rebound of gut motility, which opioids had suppressed. Dehydration from vomiting and diarrhoea is the primary medical risk during this phase and must be actively managed.
Muscle spasms and leg cramps intensify, sometimes to the point where the person cannot remain still, a phenomenon known as “kicking” (the origin of the phrase “kicking the habit”). Goosebumps (piloerection) are prominent, combined with alternating chills and hot flashes as the body’s thermoregulatory system destabilises. This is the origin of the term “cold turkey,” referring to the goosebumped skin resembling plucked poultry.
Psychological symptoms peak simultaneously: severe anxiety, irritability, dysphoria (a pervading sense that everything is wrong), and intense cravings. Some people experience significant agitation or emotional volatility. Sleep deprivation compounds every other symptom, as insomnia is typically complete during the peak phase.
Days 4 to 7: Gradual Resolution
Physical symptoms begin to subside, though the reduction is gradual rather than sudden. Gastrointestinal symptoms resolve first, typically by day 4 to 5. Muscle aches and restlessness persist longer. Sleep begins returning, though it may remain disrupted for weeks. Appetite slowly returns. The person begins to feel “more human” but is far from normal.
Psychological symptoms lag behind physical recovery. Low mood, anhedonia (inability to feel pleasure), fatigue, and irritability can persist for weeks to months. This is the post-acute withdrawal syndrome (PAWS), driven by the brain’s slow process of rebalancing its neurotransmitter systems. PAWS is a significant relapse risk factor because the person has endured the acute phase only to find that they still do not feel well, and the temptation to use opioids to relieve persistent dysphoria remains strong.
| Phase | Timeline (Short-Acting) | Timeline (Fentanyl) | Key Symptoms |
|---|---|---|---|
| Early withdrawal | 8 to 24 hours | 4 to 12 hours | Anxiety, muscle aches, yawning, watery eyes, runny nose, sweating |
| Peak withdrawal | 36 to 72 hours | 24 to 48 hours | Nausea, vomiting, diarrhoea, cramps, chills, insomnia, intense cravings |
| Resolution | Days 5 to 7 | Days 5 to 10 | Gradual symptom reduction, persistent fatigue, low mood |
| Post-acute (PAWS) | Weeks to months | Weeks to months | Anhedonia, irritability, sleep disturbance, intermittent cravings |
COWS Score: How Clinicians Measure Withdrawal Severity
The Clinical Opiate Withdrawal Scale (COWS) is the standard tool used to objectively measure withdrawal severity. It scores 11 symptoms on a scale, producing a total score that guides treatment decisions. Scores below 8 indicate mild withdrawal, 9 to 12 is moderate, 13 to 24 is moderately severe, 25 to 36 is severe, and above 36 indicates very severe withdrawal.
The COWS assessment includes resting pulse rate, sweating, restlessness, pupil size, bone and joint aches, runny nose or tearing, gastrointestinal upset, tremor, yawning, anxiety or irritability, and goosebumps. In a medically managed withdrawal setting, the COWS score determines when and how much medication to administer: higher scores trigger more aggressive symptom management.
Medical Management of Withdrawal
Medically managed withdrawal (sometimes called “medical detox”) uses specific medications to reduce symptom severity and prevent complications. The approach varies by facility and clinical protocol, but the core medications include clonidine (an alpha-2 adrenergic agonist that reduces norepinephrine overactivity, addressing anxiety, agitation, muscle aches, sweating, and runny nose), loperamide (for diarrhoea), ondansetron or metoclopramide (for nausea and vomiting), NSAIDs or paracetamol (for pain and fever), and benzodiazepines or trazodone (for insomnia and anxiety, used short-term and under close monitoring).
Increasingly, buprenorphine (Suboxone) is used during the withdrawal phase itself. Buprenorphine is a partial mu-opioid agonist that relieves withdrawal symptoms without producing the euphoria of full agonists. When properly initiated (typically 12 to 24 hours after the last opioid dose, once the COWS score reaches 8 to 12), buprenorphine can reduce withdrawal severity by 60 to 80 percent. It can then be continued as maintenance medication-assisted treatment (MAT) or tapered over days to weeks depending on the treatment plan.
The Fentanyl Complication
Withdrawal from fentanyl presents specific challenges. First, onset is faster and can be more intense because of fentanyl’s high potency. Second, fentanyl accumulates in body fat and can be released unpredictably, causing withdrawal symptoms that wax and wane rather than following the smooth progression seen with shorter-acting opioids. Third, initiating buprenorphine is more complex with fentanyl because the drug’s long tissue elimination time means precipitated withdrawal (a severe, iatrogenic withdrawal caused by administering a partial agonist too soon) can occur even 72 hours or more after the last fentanyl dose.
Many treatment facilities have adopted “low-dose” or “micro-dosing” buprenorphine induction protocols for fentanyl-dependent patients, which involve starting with very small doses of buprenorphine while the patient is still on fentanyl, gradually increasing the buprenorphine dose over several days until it is sufficient to transition off fentanyl entirely. This approach avoids precipitated withdrawal and is becoming the standard of care for fentanyl-dependent patients.
When Opioid Use Has Become More Than Occasional
If the prospect of withdrawal is what keeps you using, that is itself a diagnostic marker. Physical dependence, the state where withdrawal occurs upon cessation, develops within two to four weeks of daily opioid use. Addiction adds the psychological dimension: compulsive use despite harm, preoccupation with obtaining the drug, and continued use despite consequences to health, relationships, and functioning. Both dependence and addiction are treatable, and medically managed withdrawal is the safe, evidence-based first step.
At Phuket Island Rehab, opioid withdrawal is managed under 24-hour medical supervision using evidence-based protocols tailored to the specific opioid, the duration and severity of use, and the presence of co-occurring conditions such as depression, anxiety, or alcohol use disorder. Withdrawal management is the beginning of treatment, not the entirety of it: it is followed by comprehensive rehabilitation addressing the behavioural, psychological, and social dimensions of addiction.
Summary
Opioid withdrawal is a predictable, time-limited physiological process driven by the brain’s adaptation to chronic opioid exposure. Short-acting opioids produce withdrawal within hours, peaking at one to three days. Long-acting opioids and fentanyl follow modified timelines with specific clinical challenges. Medical management with clonidine, buprenorphine, and supportive medications reduces suffering by 60 to 80 percent. Post-acute withdrawal symptoms can persist for weeks to months and represent a significant relapse risk that requires ongoing clinical attention.
“The message I want every person considering withdrawal to hear is that it is survivable, it is time-limited, and you do not have to do it alone,” says Dr. Ponlawat Pitsuwan. “Medically managed withdrawal is a fundamentally different experience from going cold turkey. The technology exists to make this process manageable. Using it is not weakness; it is sound medical practice.”
Frequently Asked Questions
Can opioid withdrawal kill you?
Opioid withdrawal is very rarely fatal in otherwise healthy adults, unlike alcohol or benzodiazepine withdrawal which carry significant mortality risk. The primary medical dangers are dehydration from severe vomiting and diarrhoea, and aspiration of vomit in an unsupervised setting. In medically managed withdrawal, these risks are monitored and managed. However, for people with significant cardiac disease, severe debilitation, or concurrent medical conditions, medical supervision is essential.
How long does fentanyl withdrawal last compared to heroin?
Fentanyl withdrawal often begins earlier (4 to 6 hours vs 8 to 12 hours for heroin) and may last longer (7 to 14 days vs 5 to 7 days for heroin) due to fentanyl’s accumulation in fatty tissue. The peak severity is comparable but may be more intense with fentanyl due to its higher receptor affinity. The unpredictable release from fat stores can cause symptom fluctuation that heroin withdrawal typically does not produce.
Is cold turkey withdrawal from opioids safe?
While not typically life-threatening, unsupervised cold turkey withdrawal is significantly more uncomfortable than medically managed withdrawal and carries higher risks. Dehydration, falls from weakness or disorientation, and the very high risk of relapse during peak withdrawal (followed by overdose due to lost tolerance) make unsupervised withdrawal a genuinely dangerous choice. Medical management reduces symptom severity by 60 to 80 percent and dramatically improves the likelihood of completing the withdrawal process.
What is the difference between dependence and addiction?
Physical dependence means the body has adapted to the opioid and will produce withdrawal symptoms upon cessation. It can develop in anyone taking opioids regularly for two or more weeks, including patients taking prescribed painkillers appropriately. Addiction adds compulsive use despite harm, loss of control, preoccupation with the drug, and continued use despite negative consequences. A person can be dependent without being addicted, and treating the two conditions requires different approaches.
Will I feel normal after withdrawal is over?
Physical symptoms resolve within one to two weeks, but full neurological recovery takes longer. Post-acute withdrawal syndrome (PAWS) can produce low mood, fatigue, irritability, poor sleep, and intermittent cravings for weeks to months. This is the brain gradually restoring its endorphin production, dopamine receptor density, and norepinephrine balance. Exercise, adequate nutrition, sleep hygiene, and ongoing therapy all accelerate this recovery. Most people report feeling substantially better by month two to three, with continued improvement over six to twelve months.
Can I use kratom to manage opioid withdrawal at home?
Kratom contains mitragynine, a partial mu-opioid agonist that can reduce some withdrawal symptoms. However, kratom is not regulated, dosing is inconsistent, it carries its own dependence risk, and it is not a substitute for medical management. Using kratom during withdrawal replaces one opioid receptor stimulant with another, potentially prolonging the dependence cycle rather than resolving it. Medically supervised buprenorphine induction is a safer, more effective, and evidence-based approach to achieving the same goal.
Sources:
Kosten, T. R., & Baxter, L. E. (2019). Review article: Effective management of opioid withdrawal symptoms. American Journal of Addictions, 28(1), 2-14.
Wesson, D. R., & Ling, W. (2003). The Clinical Opiate Withdrawal Scale (COWS). Journal of Psychoactive Drugs, 35(2), 253-259.
Substance Abuse and Mental Health Services Administration (2020). TIP 63: Medications for Opioid Use Disorder. SAMHSA.
Hämmig, R. et al. (2016). Use of microdoses for induction of buprenorphine treatment. Drug and Alcohol Dependence, 168, 44-51.
Opioid withdrawal, withdrawal timeline, COWS, Clinical Opiate Withdrawal Scale, locus coeruleus, norepinephrine, mu-opioid receptor, endorphin, clonidine, buprenorphine, Suboxone, methadone, fentanyl, heroin, oxycodone, precipitated withdrawal, micro-dosing induction, post-acute withdrawal syndrome, PAWS, medication-assisted treatment, MAT, kratom, mitragynine, dehydration, piloerection, lacrimation, rhinorrhea, Phuket Island Rehab